NL194664B - Farmaceutische samenstelling voor het genezen van tumorachtige ziekten. - Google Patents

Farmaceutische samenstelling voor het genezen van tumorachtige ziekten.

Info

Publication number
NL194664B
NL194664B NL9220026A NL9220026A NL194664B NL 194664 B NL194664 B NL 194664B NL 9220026 A NL9220026 A NL 9220026A NL 9220026 A NL9220026 A NL 9220026A NL 194664 B NL194664 B NL 194664B
Authority
NL
Netherlands
Prior art keywords
diseases
pharmaceutical composition
curing tumor
tumor
curing
Prior art date
Application number
NL9220026A
Other languages
English (en)
Other versions
NL9220026A (nl
NL194664C (nl
Inventor
Gabor Somlyai
Original Assignee
Hyd Kutato Fejleszto Kft
Gabor Somlyai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyd Kutato Fejleszto Kft, Gabor Somlyai filed Critical Hyd Kutato Fejleszto Kft
Publication of NL9220026A publication Critical patent/NL9220026A/nl
Publication of NL194664B publication Critical patent/NL194664B/nl
Application granted granted Critical
Publication of NL194664C publication Critical patent/NL194664C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
NL9220026A 1991-10-31 1992-09-28 Farmaceutische samenstelling voor het genezen van tumorachtige ziekten. NL194664C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU343791 1991-10-31
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases
PCT/HU1992/000036 WO1993008794A1 (en) 1991-10-31 1992-09-28 Pharmaceutical products for curing tumorous diseases and process for preparing same
HU9200036 1992-09-28

Publications (3)

Publication Number Publication Date
NL9220026A NL9220026A (nl) 1994-09-01
NL194664B true NL194664B (nl) 2002-07-01
NL194664C NL194664C (nl) 2002-11-04

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9220026A NL194664C (nl) 1991-10-31 1992-09-28 Farmaceutische samenstelling voor het genezen van tumorachtige ziekten.

Country Status (22)

Country Link
US (1) US5855921A (nl)
JP (1) JP3569916B2 (nl)
KR (1) KR100253874B1 (nl)
CN (1) CN1045162C (nl)
AT (1) AT402692B (nl)
BE (1) BE1006186A3 (nl)
CA (1) CA2122612C (nl)
CH (1) CH685282A5 (nl)
CZ (1) CZ282379B6 (nl)
DE (1) DE4232465B4 (nl)
DK (1) DK170832B1 (nl)
ES (1) ES2077530B1 (nl)
FI (1) FI114010B (nl)
FR (1) FR2683148B1 (nl)
GB (1) GB2276086B (nl)
HU (1) HU208084B (nl)
IT (1) IT1255390B (nl)
LU (1) LU88175A1 (nl)
NL (1) NL194664C (nl)
NO (1) NO307031B1 (nl)
SE (1) SE513624C2 (nl)
WO (1) WO1993008794A1 (nl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018545A1 (en) * 1994-01-06 1995-07-13 Hyd Kutató-Fejlesztó Ktf. Food products for preventing development of diseases and process for preparing same
HU214593B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
WO2003068919A2 (en) * 2002-02-12 2003-08-21 The Regents Of The University Of California Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
WO2004011426A2 (en) 2002-07-30 2004-02-05 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
AU2002321678A1 (en) * 2002-09-09 2004-03-29 Boros Béla Oxygen-enriched water, treated within a magnetic field and heavy water
US7255850B2 (en) * 2002-09-13 2007-08-14 The Regents Of The University Of California Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis
CA2504313C (en) 2002-11-04 2012-01-17 Marc K. Hellerstein Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水（スーパーライトウォーター）を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (en) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (ja) * 2004-06-03 2005-12-15 Kunihiro Seki 低重水素濃度食品の生産装置
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
AU2005327332B2 (en) 2005-02-08 2010-07-22 Woodford Associates Limited Non-alcoholic beverage enriched with 1H216O
ATE505532T1 (de) * 2005-02-08 2011-04-15 Woodford Associates Ltd Mit 1h2160 angereichertes alkoholisches getränk
KR100928384B1 (ko) * 2005-03-05 2009-11-23 세르게이 파브로비치 솔로비에프 1h216o가 강화된 화장품 조성물
EA012855B1 (ru) * 2005-03-11 2009-12-30 Вада Консалтинг Лимитед Легкая фармацевтическая вода, терапевтические композиции, ее содержащие, способы их производства и применения
JP2008533005A (ja) * 2005-03-11 2008-08-21 ヴァーダ コンサルティング リミテッド 生物学的活性物質の皮内的、経皮的又は経粘膜的送達のための方法
CN101146448A (zh) * 2005-03-11 2008-03-19 维达咨询有限公司 用于消毒无生命表面的组合物
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
EP1971350A1 (en) * 2005-12-12 2008-09-24 VADA Consulting Limited Method of treating metabolic syndrome
US20080292718A1 (en) * 2005-12-12 2008-11-27 Igor Anatolievich Pomytkin Method for Suppression Appetite and Food Intake
US20080299221A1 (en) * 2005-12-12 2008-12-04 Igor Anatolievich Pomytkin Method for Decreasing Postprandial Glucose Excursion
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE202009018629U1 (de) 2009-04-21 2012-06-11 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
ES2650223T3 (es) * 2011-05-27 2018-01-17 Bristol-Myers Squibb Company Tripéptidos que incorporan deuterio como inhibidores del virus de la hepatitis C
HUP1100290A2 (en) * 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
JP2014526685A (ja) 2011-09-08 2014-10-06 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 代謝流量測定、画像化、および顕微鏡法
US20140353486A1 (en) 2011-12-07 2014-12-04 Glaxosmithkline Llc Methods for determining total body skeletal muscle mass
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
US20150313266A1 (en) * 2012-12-03 2015-11-05 Igor Anatolievich Pomytkin Food for the dietary management of burnout
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
US20150374745A1 (en) * 2014-06-30 2015-12-31 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
AU2017329108B2 (en) * 2016-09-21 2022-07-07 Botanical Water Technologies Ip Ltd Isotopic compositions
JP7262480B2 (ja) * 2018-01-02 2023-04-21 ボタニカル ウォーター テクノロジーズ アイピー リミテッド 同位体組成物
WO2019174659A1 (de) 2018-03-15 2019-09-19 Karl Bau Gmbh Verfahren und anordnung zur herstellung von deuterium reduziertem wasser
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
US5167948A (en) * 1987-08-07 1992-12-01 Mallinckrodt Medical, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Also Published As

Publication number Publication date
CA2122612A1 (en) 1993-05-13
ES2077530A1 (es) 1995-11-16
DE4232465B4 (de) 2008-11-06
SE9401406D0 (sv) 1994-04-25
NL9220026A (nl) 1994-09-01
WO1993008794A1 (en) 1993-05-13
DK170832B1 (da) 1996-02-05
ITMI922233A1 (it) 1994-03-28
LU88175A1 (fr) 1993-03-15
HU913437D0 (en) 1992-01-28
FR2683148A1 (fr) 1993-05-07
NO941590L (nl) 1994-06-23
SE513624C2 (sv) 2000-10-09
NO941590D0 (nl) 1994-04-29
NL194664C (nl) 2002-11-04
ES2077530B1 (es) 1996-07-01
IT1255390B (it) 1995-10-31
AT402692B (de) 1997-07-25
CH685282A5 (de) 1995-05-31
CN1071836A (zh) 1993-05-12
DE4232465A1 (de) 1993-05-06
JPH08501275A (ja) 1996-02-13
BE1006186A3 (fr) 1994-06-07
CA2122612C (en) 2003-02-04
ATA902992A (de) 1996-12-15
ITMI922233A0 (it) 1992-09-28
SE9401406L (sv) 1994-06-07
GB9408654D0 (en) 1994-07-20
GB2276086B (en) 1995-09-27
KR100253874B1 (ko) 2000-04-15
JP3569916B2 (ja) 2004-09-29
FI114010B (fi) 2004-07-30
NO307031B1 (no) 2000-01-31
US5855921A (en) 1999-01-05
FI941979A (fi) 1994-06-29
CZ102094A3 (en) 1994-12-15
CN1045162C (zh) 1999-09-22
CZ282379B6 (cs) 1997-07-16
FI941979A0 (fi) 1994-04-29
HU208084B (en) 1993-08-30
FR2683148B1 (fr) 1994-09-09
GB2276086A (en) 1994-09-21
KR930007461A (ko) 1993-05-20

Similar Documents

Publication Publication Date Title
NL194664B (nl) Farmaceutische samenstelling voor het genezen van tumorachtige ziekten.
NL300258I2 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van.
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A0 (fi) Farmaseuttinen ainekoostumus
NL194323B (nl) Inrichting voor het verplaatsen van bedden.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
NL194577B (nl) Preparaat voor de lang aanhoudende en gecontroleerde afgifte van medicamenteuze stoffen.
DE69115263T2 (de) Pharmazeutische zusammensetzungen.
DZ1559A1 (fr) Compositions pharmaceutiques.
NL194959B (nl) Preparaat voor het toedienen van ijzer.
FI935398A (fi) Skumreglerande medel i granulaer form
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
MX9203615A (es) Composicion farmaceutica en forma de polvo para administracion nasal.
NO920234D0 (no) Helleformulering for paafoering av anthelmintika
MX9201062A (es) Composicion para elementos curadores de moldes.
FI923371A0 (fi) En farmaceutisk formulation.
FI920845A0 (fi) Farmaceutiska kompositioner innehaollande interleukin-2.
NL194693B (nl) Werkwijze voor het bereiden van medicinale preparaten voor het behandelen van diabetes.
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.
MX9204485A (es) Composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
MX9204164A (es) Composicion farmaceutica que comprende arndh.
MX9206975A (es) Composicion farmaceutica.
ES1018817Y (es) Calzado perfeccionado.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20120928